Freenome, Inc.: Holocene Advisors, LP amends Schedule 13G stake filing
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
Holocene Advisors, LP amended its Schedule 13G stake filing for Freenome, Inc., according to SEC accession 0001172661-26-005335. The filing updates the investment adviser's reported position in the privately held cancer diagnostics company, though the headline disclosed no specific share count or percentage change. Schedule 13G amendments are typically filed when a passive investor's ownership crosses or adjusts around the 5% threshold, making the update a signal of shifting institutional interest in Freenome. Investors will watch for the full filing details to confirm whether Holocene increased, trimmed or left unchanged its stake.
Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.
Named in this story
Holocene Advisors, LP, Freenome, Inc.